Adherium Ltd
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more
Market Cap & Net Worth: Adherium Ltd (ADR)
Adherium Ltd (AU:ADR) has a market capitalization of $8.07 Million (AU$13.03 Million) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #33768 globally and #1192 in its home market, demonstrating a 25.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adherium Ltd's stock price AU$0.00 by its total outstanding shares 5210900326 (5.21 Billion).
Adherium Ltd Market Cap History: 2015 to 2026
Adherium Ltd's market capitalization history from 2015 to 2026. Data shows change from $29.80 Billion to $8.07 Million (-54.73% CAGR).
Adherium Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Adherium Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
19.74x
Adherium Ltd's market cap is 19.74 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $11.09 Billion | $2.10 Million | -$6.31 Million | 5277.50x | N/A |
| 2017 | $4.62 Billion | $2.35 Million | -$12.81 Million | 1968.36x | N/A |
| 2018 | $1.71 Billion | $5.87 Million | -$9.34 Million | 291.36x | N/A |
| 2019 | $1.29 Billion | $2.78 Million | -$11.79 Million | 465.46x | N/A |
| 2020 | $1.29 Billion | $2.22 Million | -$11.40 Million | 583.19x | N/A |
| 2021 | $508.18 Million | $401.00K | -$15.04 Million | 1267.28x | N/A |
| 2022 | $184.88 Million | $529.00K | -$10.04 Million | 349.49x | N/A |
| 2023 | $172.62 Million | $3.19 Million | -$9.86 Million | 54.03x | N/A |
| 2024 | $45.17 Million | $840.98K | -$10.22 Million | 53.71x | N/A |
| 2025 | $16.13 Million | $817.24K | -$12.68 Million | 19.74x | N/A |
Competitor Companies of ADR by Market Capitalization
Companies near Adherium Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Adherium Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Adherium Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Adherium Ltd's market cap moved from $29.80 Billion to $ 8.07 Million, with a yearly change of -54.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$8.07 Million | -50.00% |
| 2025 | AU$16.13 Million | -64.29% |
| 2024 | AU$45.17 Million | -73.83% |
| 2023 | AU$172.62 Million | -6.63% |
| 2022 | AU$184.88 Million | -63.62% |
| 2021 | AU$508.18 Million | -60.71% |
| 2020 | AU$1.29 Billion | 0.00% |
| 2019 | AU$1.29 Billion | -24.33% |
| 2018 | AU$1.71 Billion | -63.00% |
| 2017 | AU$4.62 Billion | -58.33% |
| 2016 | AU$11.09 Billion | -62.79% |
| 2015 | AU$29.80 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Adherium Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.07 Million USD |
| MoneyControl | $8.07 Million USD |
| MarketWatch | $8.07 Million USD |
| marketcap.company | $8.07 Million USD |
| Reuters | $8.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.